PropertyValue
?:definition
  • A recombinant protein-based vaccine composed of a recombinant spike (S) protein receptor-binding domain (RBD)-dimer, produced in Chinese hamster ovary (CHO) cells, of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), with potential immunomodulating and anti-coronavirus disease 2019 (COVID-19) activities. Upon intramuscular administration of the recombinant S-protein RBD-dimer SARS-CoV-2 vaccine, the S protein RBD-dimer activates the immune system to create anti-SARS-CoV-2 S protein antibodies. The antibodies recognize and neutralize the S protein and kill SARS-CoV-2. This prevents SARS-CoV-2 infection. S-protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus. The dimeric form of SARS-CoV-2 RBD may increase its immunogenicity.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C5420411_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C5420411_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all